Dr. Kalevi Kurkijärvi (65)
Chairman & CEO, Founding Partner
Kalevi is the founder and main owner of Innomedica. He is one of the pioneers of the Finnish biotech industry with more than 30 years of experience in the international business environment including sales & marketing, manufacturing, R&D, business development, corporate management, entrepreneurship and 10+ years of experience in private equity financing. Kalevi has a PhD in Biochemistry and Molecular Biology from the University of Turku. Additionally, he has completed the Management and Business Administration Program at Turku School of Economics and holds the Board Director Examination approved by the Chamber of Commerce.
Kalevi is Chairman & CEO of Biketex Oy, his family company in import-export trading. He is co-founder and former Executive Chairman of Bio Fund Mangement Oy, a biotech VC company. He has acted in several managerial positions at Perkin Elmer Wallac, most recently as Executive Vice President and Business Division Director. He was the CEO of Pharmacia Diagnostics Production. Kalevi has gained extensive administrative history and corporate development views as well as licensing, M&A and IPO experience of high tech companies by serving as a director or chairman in about 30 international companies such as FibroGen Inc., Paratek Pharmaceuticals Corp., Ark Therapeutics Corp., Biotie Therapies Oyj, Hytest Oy, Hormos Medical Oy, Rados Technology Oy, MAP Medical Technologies Oy, as well as many others.
Dr. Risto Lammintausta (67)
Risto has extensive experience at a senior level with more than 35 years of experience in the Finnish Pharma and Biopharma Industry including pre-clinical and clinical development of pharmaceuticals as well as licensing and M&A. Risto is a qualified physician (M.D.) and has a PhD in Pharmacology and Clinical Pharmacology from the University of Turku with an MBA from the Turku School of Economics.
Risto is co-founder and CEO of Hormos Medical Oy and Director in QuatRx Pharmaceutical Inc. He has served both as Vice President of R&D and Research Director in Orion Pharma Corp. for close to 20 years. He is acting as Director and/or Adviser of several Biopharma Companies and High Tech Industry Associations with an excellent network.
Timo Kruskopf (58)
Timo has close to 30 years of experience in Marketing Communication Business with an education in Business Administration. His core competencies are in the marketing strategies, communication planning and revenue performance management. Timo is a well-liked presenter and marketing coach- strategy-to-action team player who has participated in several national and international industry foresight processes with companies such as Nokia, Eurescom, DT and BT among others.
Timo is the Managing Partner of ID BBN which has developed under his leadership into a full scale business marketing specialist with experienced team and top-of-class methods and processes. Besides managing responsibilities he is on lead of key customers planning processes, extending their ability to vision and challenging conventions. Timo also plays an active role in the international BBN: The Business Branding Network´s executive operations.